BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36570769)

  • 1. Screening and characterization of inhibitory vNAR targeting nanodisc-assembled influenza M2 proteins.
    Yu C; Ding W; Zhu L; Zhou Y; Dong Y; Li L; Liu J; Wang Y; Li Z; Zhu L; Chen F; Ruan M; Qian D; Wang Y; Wu B; Xu H; Li M; Bi Y; Wang H; Wang W; Chao P; Xing L; Shen B; Dai H; Zha L; Zhao H; Wang J
    iScience; 2023 Jan; 26(1):105736. PubMed ID: 36570769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
    Jiang X; Sun S; Li Z; Chen M
    Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
    Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
    Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
    Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
    Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.
    Pissawong T; Maneewatch S; Thueng-In K; Srimanote P; Dong-din-on F; Thanongsaksrikul J; Songserm T; Tongtawe P; Bangphoomi K; Chaicumpa W
    Virol J; 2013 May; 10():148. PubMed ID: 23672256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and next-generation sequencing analysis of a large phage-displayed V
    Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
    Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
    [No Abstract]   [Full Text] [Related]  

  • 7. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.
    De Filette M; Martens W; Roose K; Deroo T; Vervalle F; Bentahir M; Vandekerckhove J; Fiers W; Saelens X
    J Biol Chem; 2008 Apr; 283(17):11382-7. PubMed ID: 18252707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses.
    Zhong W; He J; Tang X; Liu F; Lu X; Zeng H; Vafai A; Fu TM; Katz JM; Hancock K
    J Immunol Methods; 2011 Jun; 369(1-2):115-24. PubMed ID: 21570401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring shark VNAR antibody against infectious diseases using phage display technology.
    Lim HT; Kok BH; Leow CY; Leow CH
    Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
    Hashemi H; Pouyanfard S; Bandehpour M; Noroozbabaei Z; Kazemi B; Saelens X; Mokhtari-Azad T
    PLoS One; 2012; 7(9):e45765. PubMed ID: 23029232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum).
    Li W; Chen M; Wang T; Feng X; Jiang X; Dong X; Zhang H; Tang X; Tian R; Zhang Y; Li Z
    Int J Biol Macromol; 2024 Jun; 273(Pt 2):133082. PubMed ID: 38878923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
    Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
    Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.
    Shim BS; Choi YK; Yun CH; Lee EG; Jeon YS; Park SM; Cheon IS; Joo DH; Cho CH; Song MS; Seo SU; Byun YH; Park HJ; Poo H; Seong BL; Kim JO; Nguyen HH; Stadler K; Kim DW; Hong KJ; Czerkinsky C; Song MK
    PLoS One; 2011; 6(11):e27953. PubMed ID: 22140491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of native and functional influenza A virus matrix 2 proton selective ion channel.
    Desuzinges Mandon E; Traversier A; Champagne A; Benier L; Audebert S; Balme S; Dejean E; Rosa Calatrava M; Jawhari A
    Protein Expr Purif; 2017 Mar; 131():42-50. PubMed ID: 27825980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.
    Wang L; Hess A; Chang TZ; Wang YC; Champion JA; Compans RW; Wang BZ
    Nanomedicine; 2014 Feb; 10(2):473-82. PubMed ID: 23988715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein.
    Chen YL; Lin JJ; Ma H; Zhong N; Xie XX; Yang Y; Zheng P; Zhang LJ; Jin T; Cao MJ
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.
    Wei G; Meng W; Guo H; Pan W; Liu J; Peng T; Chen L; Chen CY
    PLoS One; 2011; 6(12):e28309. PubMed ID: 22164266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination induced antibodies to recombinant avian influenza A virus M2 protein or synthetic M2e peptide do not bind to the M2 protein on the virus or virus infected cells.
    Swinkels WJ; Hoeboer J; Sikkema R; Vervelde L; Koets AD
    Virol J; 2013 Jun; 10():206. PubMed ID: 23800100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
    Wang W; Huang B; Wang X; Tan W; Ruan L
    Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
    Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.